Frequency of immediate adverse effects associated with apheresis donation.
about
Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.Risk factors associated with the occurrence of adverse events in plateletpheresis donation.Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures.Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program.Donor Safety in Haemapheresis: Development of an Internet-Based Registry for Comprehensive Assessment of Adverse Events from Healthy Donors.Comprehensive analysis of citrate effects during plateletpheresis in normal donors.Comparison of Plateletpheresis on the Fenwal Amicus and Fresenius Com.Tec Cell Separators.Allogeneic peripheral blood stem cell collection as of 2008.Unique donor-suitability issues.Leukapheresis protocol for nonhuman primates weighing less than 10 kg.Adverse events associated with apheresis procedures: Incidence and relative frequencyA Retrospective Analysis of Apheresis Donor Deferral and Adverse Reactions at a Tertiary Care Centre in India.No association between frequent apheresis donation and risk of fractures: a retrospective cohort analysis from Sweden.Bone density in apheresis donors and whole blood donors.Study of Single Donor Platelet (SDP) Preparation by Baxter CS 3000 plus and Haemonetics MCS plus.Effectiveness of low-dose oral calcium carbonate for the prevention of citrate-related toxicity in peripheral blood stem cell collection.Donor safety in triple plateletpheresis: results from the German and Austrian Plateletpheresis Study Group multicenter trial.Effectiveness of low-dose oral calcium carbonate for the prevention of citrate-related toxicity in peripheral blood stem cell collection.Hematomas in multicomponent apheresis: searching for related factors.Iron supplementation and 2-unit red blood cell apheresis: a randomized, double-blind, placebo-controlled study.A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).How we approach an apheresis request for a Category III, Category IV, or noncategorized indication.Adverse Events During Apheresis Procedures: Audit at a Tertiary Hospital.The effects of warming methods on temperature, cardiac function and cytokines in plateletpheresis donors.
P2860
Q33157218-C7AB94AA-1AE9-4C38-85FC-46DB5F76C9C4Q33164521-55771C4C-8873-4A6C-B53D-E942BF8A00C8Q33340214-C550DE9C-72EF-4160-A7A1-B85FF9563834Q33726826-E2AEC255-5AA8-499E-B11B-45DD183E276CQ33805801-92650C94-9BBB-4E32-8ACB-178B901461DEQ34090886-0F46FF3D-5833-492E-90C7-E37FA5D51DF8Q34790959-756F9F9A-048D-4462-BEB3-E062CA0EC239Q35154218-E02C4DA4-2010-4B8D-9519-749296B60DFFQ36458599-D91114DB-0322-4176-AA99-61A88F5BEEC0Q36542930-8215BAFE-5360-4569-89EC-F8D1B556D837Q36732672-656AC981-5D47-4E66-8D18-15996495AAB1Q37542963-C93A4C42-99BA-4721-8149-E095F362F424Q39177594-44B14302-95EF-4051-B779-C7F6A75906A5Q41703497-1735AF97-521C-4E17-8CAA-83E2C794019DQ41813327-ABE9D647-B5BD-4D1A-BAAA-0FF5F7985437Q42343543-23C884EB-23CA-4FB5-A55D-247DECFE72CDQ44229001-D0E37A9D-AE37-4BFD-B54C-76F3D481740CQ47127201-F0C5C015-5C2C-483B-A9A8-1D770C509AFDQ50711384-12D46F6C-9623-4663-883B-569012FB3EE9Q50785925-ECC599BF-C89C-47C8-9937-F7805A1F0654Q50787121-5E20B7E0-1DF7-4EC2-B79F-3721D21885E2Q51902380-DCF04CAF-FD87-43AE-A440-C121461280EDQ53508615-F94E8DE1-B0F7-4403-AB89-538CA7578039Q53544180-9E725B13-DB9E-4788-85EF-A3A8652EAE77
P2860
Frequency of immediate adverse effects associated with apheresis donation.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Frequency of immediate adverse effects associated with apheresis donation.
@ast
Frequency of immediate adverse effects associated with apheresis donation.
@en
type
label
Frequency of immediate adverse effects associated with apheresis donation.
@ast
Frequency of immediate adverse effects associated with apheresis donation.
@en
prefLabel
Frequency of immediate adverse effects associated with apheresis donation.
@ast
Frequency of immediate adverse effects associated with apheresis donation.
@en
P2093
P1433
P1476
Frequency of immediate adverse effects associated with apheresis donation.
@en
P2093
Ciavarella D
Randels MJ
Sniecinski I
P304
P356
10.1046/J.1537-2995.1998.381098440858.X
P577
1998-10-01T00:00:00Z